Rituximab Studied as Add-On Therapy for New-Onset Myasthenia Gravis

A single infusion of rituximab early after the onset of generalized myasthenia gravis improves outcomes at 16 weeks.

Related Keywords

Stockholm ,Sweden ,Fredrik Piehl ,Karolinska University Hospital ,Healthday News ,Myasthenia Gravis Activities ,Daily Living ,Myasthenia Gravis Quality ,Quantitative Myasthenia Gravis ,